Search Results for: OGT

717 interactions involving OGT - O-linked N-acetylglucosamine (GlcNAc) transferase found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
IGF2BP2 insulin like growth factor 2 mRNA binding protein 2
  • Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
  • Type II diabetes mellitus
IGF2BP3 insulin like growth factor 2 mRNA binding protein 3
  • Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
IGKV2D-29 immunoglobulin kappa variable 2D-29
IK IK cytokine
  • mRNA Splicing - Major Pathway
IKBIP IKBKB interacting protein
  • Regulation of NF-kappa B signaling
ILF2 interleukin enhancer binding factor 2
  • Neutrophil degranulation
  • PKR-mediated signaling
ILF3 interleukin enhancer binding factor 3
  • Regulation of CDH11 gene transcription
  • Regulation of CDH11 gene transcription
  • PKR-mediated signaling
ILK integrin linked kinase
  • Localization of the PINCH-ILK-PARVIN complex to focal adhesions
  • Cell-extracellular matrix interactions
ILKAP ILK associated serine/threonine phosphatase
IMPDH1 inosine monophosphate dehydrogenase 1
  • Neutrophil degranulation
  • Purine ribonucleoside monophosphate biosynthesis
  • Potential therapeutics for SARS
  • Azathioprine ADME
  • NADH
  • Mycophenolate mofetil
  • Ribavirin
  • Mycophenolic acid
  • Mercaptopurine
  • 6-Chloropurine Riboside, 5'-Monophosphate
  • VX-148
  • Taribavirin
  • Leber congenital amaurosis (LCR)
  • Retinitis pigmentosa (RP)
IMPDH2 inosine monophosphate dehydrogenase 2
  • Neutrophil degranulation
  • Purine ribonucleoside monophosphate biosynthesis
  • Potential therapeutics for SARS
  • Azathioprine ADME
  • NADH
  • Mycophenolate mofetil
  • Ribavirin
  • Mycophenolic acid
  • Mercaptopurine
  • Selenazole-4-carboxyamide-adenine dinucleotide
  • 6-Chloropurine Riboside, 5'-Monophosphate
  • Inosinic Acid
  • VX-148
IPO5 importin 5
  • vRNP Assembly
IRF3 interferon regulatory factor 3
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
  • SARS-CoV-1 activates/modulates innate immune responses
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • Evasion by RSV of host interferon responses
IRS4 insulin receptor substrate 4
  • IRS-related events triggered by IGF1R
IST1 IST1 factor associated with ESCRT-III
  • Neutrophil degranulation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
ISYNA1 inositol-3-phosphate synthase 1
  • Synthesis of IP2, IP, and Ins in the cytosol
  • 2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate
  • 2-Deoxy-Glucitol-6-Phosphate
  • Glycerin
JMJD6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase
  • HDMs demethylate histones
  • Protein hydroxylation
KARS1 lysyl-tRNA synthetase 1
  • Selenoamino acid metabolism
  • Cytosolic tRNA aminoacylation
  • Mitochondrial tRNA aminoacylation
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Lysine
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
KATNA1 katanin catalytic subunit A1
KHDRBS1 KH RNA binding domain containing, signal transduction associated 1
  • PTK6 Regulates Proteins Involved in RNA Processing

Page 14 out of 36 pages